The Evolving Pharma M&A Landscape

Pharmaceutical industry growth rates have halved since 2003, and fell below 5% in 2008. The sector is under unprecedented pressure ??

• Executive Summary
  • Pharmaceutical industry pressure points
  • Can mega-mergers solve the industry's problems?
  • Big pharma M&A
  • Generic industry M&A
  • Biotech industry M&A
• Chapter 1 Pharmaceutical industry pressure points
  • Summary
  • Introduction
  • Diminishing returns
  • Stock market reaction
  • Key factors behind the squeeze on big pharma
  • Patent expiries
  • Pharmaceutical cost-containment
  • Deteriorating R&D risk/return ratios
  • Adapting to the new market environment
  • Cost-cutting and efficiency increases
  • Enhancing pipelines
  • Corporate restructuring
• Chapter 2 Can mega-mergers solve the industry's problems?
  • Summary
  • Introduction
  • The last wave of mega-mergers
  • Mega-merger legacies
  • Pfizer ??